February 2017
J0570 replaces J3490, J3590 when billing for Probuphine® (buprenorphine)
The Centers for Medicare & Medicaid Services has established a permanent procedure code for specialty medical drug Probuphine® (buprenorphine), effective Jan. 1, 2017.
All services from Aug. 1, 2016, through Dec. 31, 2016, will continue to be reported with code J3490 or J3590. All services performed on and after Jan. 1, 2017, must be reported with J0570.
The National Drug Code is 58284-0100-14.
Prior authorization is still required for Probuphine (buprenorphine) when reported with the new procedure code J0570, unless the group has opted out of the Specialty Pharmacy Prior Authorization Program.
|